5 Key Takeaways

• 1

  Over 300 million people worldwide are affected by more than 7,000 distinct rare diseases, most of which have a genetic basis.

• 2

  Long-read whole-genome sequencing improves diagnostic yield by resolving complex genetic variants often missed by conventional methods.

• 3

  A multi-omic approach, incorporating the genome, transcriptome, methylome, and chromatin epigenome, provides a comprehensive view of rare disease biology.

• 4

  Advances in multi-omic sequencing enable integrated analysis of multiple biological layers, reducing reliance on fragmented testing methods.

• 5

  Collaboration in the sequencing ecosystem is enhancing multi-omic workflows, bridging the gap between research and clinical applications.